期刊文献+

4-羟基肉桂酰胺对糖尿病小鼠的降血糖效应及机制研究

Hypoglycemic Effect and Mechanism of 4-Hydroxycinnamamide in Diabetic Mice
下载PDF
导出
摘要 探讨4-羟基肉桂酰胺(4-Hy)作为胰岛素受体增敏剂在糖尿病动物模型上的降糖作用。采用STZ诱导胰岛素缺陷型小鼠模型,对小鼠随机分组:对照组、胰岛素治疗组(Insulin,1 U/kg)、不同剂量4-羟基肉桂酰胺治疗组(2.5、5 mg/kg)、联合给药组(4-Hy2.5 mg/kg+Insulin组、4-Hy5 mg/kg+Insulin组)。对照组小鼠等体积DMSO给药;测定小鼠血糖浓度和血清中胰岛素、胰高血糖素、C肽水平,组织中相关信号通路的表达,基因mRNA的表达水平。结果表明:4-Hy与胰岛素联用能显著延长胰岛素的降血糖效果(p<0.001);降低了小鼠血清中的平均C肽水平和胰高血糖素水平;在小鼠组织中,4-Hy与胰岛素联用组的p-IR1150/1151及p-AKT(Ser473)表达显著增强(p<0.01);在肝脏组织中,4-Hy与胰岛素联用组的糖异生水平显著降低(p<0.001),糖原合成及糖原分解水平显著提高(p<0.01)。说明4-羟基肉桂酰胺作为胰岛素受体的增敏剂可以显著增强胰岛素的降血糖效应。 To investigate the hypoglycemic effect of 4-hydroxycinnamamide(4-Hy), an insulin receptor sensitizer, in an animal model of diabetes. The STZ-induced insulin-deficient mouse model was used, and the mice were randomly grouped into the following groups: control group, insulin treatment group(1 U/kg), different doses of 4-hydroxycinnamamide treatment group(2.5 and 5 mg/kg), and coadministration group(4-Hy2.5 mg/kg+insulin group and 4-Hy5 mg/kg+insulin group). In the control group, the mice were given an equal volume of the DMSO, blood glucose concentrations, serum insulin, glucagon, and C-peptide levels, the expression of related signaling pathway components in tissues, and the expression levels of the genes. The results showed that the combination of 4-Hy and insulin significantly prolonged the hypoglycemic effect of insulin(p<0.001) and reduced the average C-peptide and glucagon levels in the serum of mice;in mouse tissues, and the expression of p-IR1150/1151 and p-AKT(Ser473) was significantly enhanced in the group treated with the combination of 4-Hy and insulin(p<0.01). In liver tissues, the expression of 4-Hy and insulin was significantly enhanced(p<0.01). Gluconeogenesis was strongly reduced(p<0.001), and glycogen synthesis and glycogenolysis were significantly increased(p<0.01) in the 4-Hy and insulin combination group. These findings indicate that 4-hydroxycinnamamide, a sensitizer of insulin receptors, can significantly enhance the hypoglycemic effect of insulin.
作者 曾玉萍 陈敏华 管巧丽 刘冠甫 张冬英 吴晓云 ZENG Yuping;CHEN Minhua;GUAN Qiaoli;LIU Guanfu;ZHANG Dongying;WU Xiaoyun(College of Food Science,Yunnan Agricultural University,Kunming 650506,China;Key Laboratory of Pu'er Tea Science,Yunnan Agricultural University,Ministry of Education,Kunming 650506,China;College of Science,Yunnan Agricultural University,Kunming 650506,China)
出处 《热带农业科学》 2024年第1期74-80,共7页 Chinese Journal of Tropical Agriculture
基金 国家自然科学基金(No.81760667) 云南省农业联合专项面上项目(No.202301BD070001-097)。
关键词 4-羟基肉桂酰胺 胰岛素受体增敏剂 糖尿病 降血糖效应 4-hydroxycinnamamide insulin receptor sensitizer diabetes mellitus hypoglycemic effect
  • 相关文献

参考文献3

二级参考文献30

  • 1Gmnell M,Savage DB,Chatterjee VK, et al. The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation [ J ]. J Clin Endocrinol Metab, 2003, 88(6) :2412 - 2421.
  • 2Stumvoll M. Thiazolidinediones- some recent developments[J]. Expert Opin Investig Drugs, 2003, 12(7): 1179 -1187.
  • 3Wilmsen HM, Ciaraldi TP, Carter L, et al. Thaiazohdinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J]. Am J Physiol Endocrinol Metab, 2003, 285(2) :E354- E362.
  • 4Verges B. Clinical interest of PPARs ligands[J]. Diabetes Metab, 2004, 30(1):7-12.
  • 5Wang M, Tafuri S. Modulation of PPARγ activity with pharmaceutical agents: treatment of insulin resistarme and atherosclerosis[J]. J Cell Biochem, 2003, 89(1) :38 -47.
  • 6Doggrell S. Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs [ J ] ? Expert Opin Imestig Drugs, 2003,12(4) :713 - 716.
  • 7Kazerooni T, Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome [ J ]. Gynecol Endocrinol , 2003, 17 ( 1 ) :51 - 56.
  • 8ford JM, Flight IH, Norman RJ. Insulin-sensitising drugs(metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome[ J]. Godtrane Database Syst Rev, 2003, (3) :CD003053.
  • 9Schupp M, Janke J, Clasen R, et al. Angiotensin type 1 receptor blockers induce peroxisome proliferator-aetivated receptor-gamma activity[J]. Circulation, 2004, 109(17):2054 - 2057.
  • 10Abella A, Marti L, Camps M, et al. Semicarbazide-semifive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats[J]. Diabetes, 2003, 52(4) : 1004- 1013.

共引文献5289

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部